Peripheral Blood CD34-positive Cells Enumeration as Predictor of Stem Cell Harvest

Peripheral Blood CD34+ Cells Count as Predictor of Stem Cell Harvest After Chemotherapy and G-CSF. A Single Center Experience

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02023814

Enrollment

250

Registered

2013-12-30

Start date

2002-01-31

Completion date

2013-10-31

Last updated

2013-12-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Stem Cell Harvest Failure

Brief summary

Stem cell mobilization procedures after chemotherapy and G-CSf performed at our Institution between 2002 and 2013 were reviewed in order to define prognostic factors for optimal harvest

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

16 Years to 75 Years

Healthy volunteers

Inclusion criteria

* Mobilization with chemotherapy and G-CSF * Years 2002-2013

Exclusion criteria

* mobilization with G-CSF alone * mobilization with plerixafor

Design outcomes

Primary

Measure	Time frame	Description
Blood Stem cell harvest failure rate	7 days from hematological recovery	Patients not able to harvest at least 2x10e6 CD34+/Kg in the specified time frame are considered failures

Outcome results